3D Bioprinted skin models for drug screening
|
Research Initiative
|
FDA
|
NCATS
|
|
|
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead
|
Research Initiative
|
FDA
|
NCI
|
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and prostate cancer
|
Research Initiative
|
CDC
|
|
2020
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and renal cell carcinoma
|
Research Initiative
|
CDC
|
|
2018
|
|
A nested case-control study of circulating per- and polyfluoroalkyl substances (PFAS) and uterine and ovarian cancers
|
Research Initiative
|
CDC
|
|
2019
|
|
A nested case-control study of serum PFAS and testicular cancer in Air Force servicemen
|
Research Initiative
|
CDC
|
|
2019
|
|
A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of escalating multiple oral doses of AG-348 in subjects with stable sickle cell disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
|
Research Initiative
|
CDC
|
|
1998
|
|
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease
|
Research Initiative
|
FDA
|
NHLBI
|
|
|
A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial
|
Research Initiative
|
CDC
|
NIAID
|
2015
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-1: Immune Modulators (ACTIV-1)
|
Research Initiative
|
FDA, ASPR
|
NCATS
|
2020
|
|
Accelerating COVID-19 Therapeutic Interventions and Vaccines-6: Outpatient Repurposed Drugs (ACTIV-6)
|
Research Initiative
|
CDC, FDA, ASPR
|
NIAID, NHLBI, NCATS
|
2021
|
|
Accelerating Medicines Partnership® Schizophrenia (AMP SCZ)
|
Research Initiative
|
FDA
|
|
2020
|
|
Adaptive Optics Imaging of Outer Retinal Diseases
|
Research Initiative
|
FDA
|
|
|
|
Adaptive Optics Retinal Imaging
|
Research Initiative
|
FDA
|
NEI
|
|
|
Adolescent Brain Cognitive Development (ABCD) Study
|
Research Initiative
|
CDC
|
NCI, NIAAA, NICHD, NIDA, NIMH, NIMHD, NINDS, OD/ DPCPSI/ OBSSR
|
2016
|
|
Advancing American Kidney Health Initiative
|
Research Initiative
|
CDC, CMS, FDA, ASPE, ASPR, HRSA, IHS, OCR
|
NIEHS, NIDDK
|
2019
|
|
Alcohol Metabolism, Functional Consequences and Apoptosis Signaling Mechanism
|
Research Initiative
|
FDA
|
NIAAA
|
|
|
AMP Bespoke Gene Therapy Program/Bespoke Gene Therapy Consortium (BGTC)
|
Research Initiative
|
FDA
|
NCATS, NHLBI, NIMH, NINDS
|
2019
|
|
Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)
|
Research Initiative
|
FDA
|
NCATS, NCI, NIAAA, NIDA, NINDS
|
2011
|
|
Ancillary Swab Study to PREVENT-19 trial: Swab your Nose Inside to Find inFection (SNIFF)
|
Research Initiative
|
ASPR, CDC, FDA
|
|
2021
|
|
Antiviral Program for Pandemics
|
Research Initiative
|
ASPR
|
NIAID, NCATS, OD/ DPCPSI/ ORIP
|
2020
|
|
Assay optimization and screening for measuring the kinetics of antibacterial resistance emergence
|
Research Initiative
|
FDA
|
NCATS
|
|
|
Assessment of Inhalation Exposures to Indoor and Occupational Aerosols
|
Research Initiative
|
CDC
|
NIEHS
|
2014
|
|